Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation

被引：40

作者：

Hu, Yueshan ^{[1
]}

Fahmy, Hesham ^{[1
]}

Zjawiony, Jordan K. ^{[2
,3
]}

Davies, Gareth E. ^{[1
,4
,5
]}

机构：

[1] S Dakota State Univ, Dept Pharmaceut Sci, Coll Pharm, Brookings, SD 57007 USA

[2] Univ Mississippi, Sch Pharm, Pharmaceut Sci Res Inst, University, MS 38677 USA

[3] Univ Mississippi, Sch Pharm, Dept Pharmacognosy, University, MS 38677 USA

[4] Avera Behav Hlth Ctr, Avera Inst Human Behav Genet, Sioux Falls, SD 57108 USA

[5] Univ S Dakota, Dept Psychiat, Sanford Sch Med, Vermillion, SD 57069 USA

来源：

FITOTERAPIA | 2010年 / 81卷 / 04期

关键词：

Berberine; Evodiamine; Combination; Human white preadipocyte; Differentiation; GATA; ACTIVATED PROTEIN-KINASE; IN-VITRO; ADIPOCYTE DIFFERENTIATION; MECHANISM DISTINCT; SUPPRESSION; OBESITY; GAMMA; GATA;

D O I：

10.1016/j.fitote.2009.09.012

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

It has been reported that the botanical alkaloids, berberine and evodiamine inhibit mouse preadipocyte 3T3-L1 differentiation. The aim of this study was to investigate the effect and transcriptional impact of berberine and evodiamine individually and in combination on human white preadipocyte (HWP) differentiation. We have shown that treatment with 8 mu M berberine or 4 mu M evodiamine resulted in a major inhibition of HWP differentiation accompanied by up-regulation of both GATA binding protein 2 and 3 (GATA-2 and GATA-3) mRNA and protein expression, suggesting that both compounds may have excellent potential as agents to prevent obesity. (C) 2009 Elsevier BM. All rights reserved.

引用

页码：259 / 268

页数：10

共 43 条

[1] Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].

Adams, M ;

Montague, CT ;

Prins, JB ;

Holder, JC ;

Smith, SA ;

Sanders, L ;

Digby, JE ;

Sewter, CP ;

Lazar, MA ;

Chatterjee, VKK ;

O'Rahilly, S .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153

[2] BERBERINE SULFATE - ANTIMICROBIAL ACTIVITY, BIOASSAY, AND MODE OF ACTION [J].

AMIN, AH ;

SUBBAIAH, TV ;

ABBASI, KM .

CANADIAN JOURNAL OF MICROBIOLOGY, 1969, 15 (09) :1067-&

[3] Inhibition of chemical carcinogenesis by berberine in rats and mice [J].

Anis, KV ;

Rajeshkumar, NV ;

Kuttan, R .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (05) :763-768

[4]

[Anonymous], 2000, Arch Intern Med, V160, P898

[5]

Auwerx J, 1996, J MOL MED, V74, P347, DOI 10.1007/s001090050036

[6] Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine [J].

Brusq, Jean-Marie ;

Ancellin, Nicolas ;

Grondin, Pascal ;

Guillard, Raphaelle ;

Martin, Sandrine ;

Saintillan, Yannick ;

Issandou, Marc .

JOURNAL OF LIPID RESEARCH, 2006, 47 (06) :1281-1288

[7] Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK [J].

Cheng, Zhe ;

Pang, Tao ;

Gu, Min ;

Gao, An-Hui ;

Xie, Chuan-Ming ;

Li, Jing-Ya ;

Nan, Fa-Jun ;

Li, Jia .

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (11) :1682-1689

[8] Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages [J].

Chiou, WF ;

Sung, YJ ;

Liao, JF ;

Shum, AYC ;

Chen, CF .

JOURNAL OF NATURAL PRODUCTS, 1997, 60 (07) :708-711

[9] In vitro effects of chorionic gonadotropin hormone on human adipose development [J].

Dos Santos, Esther ;

Dieudonne, Marie-Noelle ;

Leneveu, Marie-Christine ;

Pecquery, Rene ;

Serazin, Valerie ;

Giudicelli, Yves .

JOURNAL OF ENDOCRINOLOGY, 2007, 194 (02) :313-325

[10] In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes [J].

El Hadri, K ;

Glorian, M ;

Monsempes, C ;

Dieudonné, MN ;

Pecquery, R ;

Giudicelli, Y ;

Andreani, M ;

Dugail, I ;

Fève, B .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :15130-15141

← 1 2 3 4 5 →